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A B S T R A C T
Purpose: Epilepsy patients consider driving issues to be one of their most serious concerns. Ideally, decisions
regarding fitness to drive should be based upon thorough evaluations by specialists in epilepsy care. In 2009, an
EU directive was published aiming to harmonize evaluation practices within European countries, but, despite
these recommendations, whether all epileptologists use the same criteria is unclear. We therefore conducted this
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study to investigate routine practices on how epileptologists at European epilepsy centers evaluate fitness to
drive.
Methods: A questionnaire was sent to 63 contact persons identified through the European Epi-Care and the E-
pilepsy network. The questionnaire addressed how fitness-to-drive evaluations were conducted, the involvement
of different professionals, the use and interpretation of EEG, and opinions on existing regulations and guidelines.
Results: The questionnaire was completed by 35 participants (56 % response rate). Results showed considerable
variation regarding test routines and the emphasis placed on the occurrence and extent of epileptiform dis-
charges revealed by EEG. 82 % of the responders agreed that there was a need for more research on how to better
evaluate fitness-to-drive in people with epilepsy, and 89 % agreed that regulations on fitness to drive evaluations
should be internationally coordinated.
Conclusion: Our survey showed considerable variations among European epileptologists regarding use of EEG
and how findings of EEG pathology should be assessed in fitness-to-drive evaluations. There is a clear need for
more research on this issue and international guidelines on how such evaluations should be carried out would be
of value.
1. Introduction
Several studies have indicated that active epilepsy is associated with
an increased risk of motor vehicle accidents [1–6]. People with epilepsy
(PWE) consider driving issues to be one of the concerns with the most
impact on quality of life [1,7], and a balance needs to be achieved
between society’s need for traffic safety and patients’ wish for au-
tonomy and independence by being able to hold a driving license. In
2003, an “Epilepsy and driving working group” was established to
harmonize regulations within the European Union (EU) regarding cri-
teria for epilepsy patients being able to hold a Group 1 license (ordinary
driving license for driving cars, motorcycles, and mopeds, not including
taxis) and a Group 2 license (commercial or vocation driving license for
large goods vehicles, lorries, passenger-carrying vehicles with 9 or more
seats, also including taxis, and horse boxes). The recommendations of
the working group for regulations for PWE holding these licenses were
implemented as an EU directive in 2009 with harmonization on the
definition on epilepsy, periods of seizure freedom, and seizure types
acceptable for the patient being declared fit to drive, see Table 1 [8].
Guidelines on when and how to conduct EEG, or how to evaluate in-
terictal EEG pathology with respect to being fit to drive were not in-
cluded, except that drivers with a groupe 2 license have to have a
normal EEG.
Subsequently, national regulations followed the EU directive and
other non-EU countries have, to varying extents, also adopted the
regulations. The directive also states that EU member states are allowed
to impose stricter standards than the minimum EU requirements. This
flexibility regarding the implementation of internationally agreed
standards provides the opportunity for variations in national regula-
tions, including different approaches on how fitness-to-drive evalua-
tions are performed in epilepsy centers across Europe. In the vast ma-
jority of EU and EEA countries a specialist (neurologist) or a general
Table 1
Summary over regulations from the Directive 2006/126/EC of the European Parliament and of the Council of 20 December 2006 on driving licenses with regard to
epilepsy [8].
Group 1: drivers of motorcycles and cars Group 2: drivers of trailers and busses
Definitions Epilepsy: two or more epileptic seizures, less than five years apart.
A provoked epileptic seizure: seizure with a recognizable causative factor that is avoidable.
General rules Under license review until seizure-free for at least five years. Should be without anti-epileptic medication for the required period
of seizure freedom. No relevant cerebral pathology established and
no epileptiform activity on the electroencephalogram (EEG).
Provoked epileptic seizure Able to drive on an individual basis, subject to neurological
opinion.
Able to drive on an individual basis, subject to neurological opinion.
EEG and neurological assessment performed after the acute episode.
A person with a structural intra-cerebral lesion who has increased
risk of seizures should not be able to drive vehicles of group 2 until
the epilepsy risk has fallen to at least 2 % per annum.
First or single unprovoked seizure Able to drive after a period of six months without seizures. Able to drive once five years’ freedom from further seizures has been
achieved without the aid of anti-epileptic drugs.
Other loss of consciousness Should be assessed according to the risk of recurrence while
driving.
Should be assessed according to the risk of recurrence while driving.
The risk of recurrence should be 2 % per annum or less.
Epilepsy Fit to drive after a one-year period free of further seizures. Fit to drive after 10 years freedom from further seizures without the
aid of anti-epileptic drugs. Possible exceptions: recognized good
prognostic indicators or ‘juvenile epilepsy’.
Drivers with disorders with an increased risk of seizures, even if
seizures have not yet occurred, should not be able to drive vehicles of
group 2 until the epilepsy risk has fallen to at least 2 % per annum.
Seizures exclusively in sleep Fit to drive so long as this pattern has been established for a
period corresponding to the seizure-free period required for
epilepsy.
Seizures without influence on
consciousness or the ability to act
Fit to drive so long as this pattern has been established for a
period corresponding to the seizure-free period required for
epilepsy.
Seizures because of a physician-directed
change or reduction of anti-epileptic
therapy
Patient may be advised not to drive from the commencement
of the period of withdrawal and thereafter for a period of six
months after cessation of treatment. Seizures occurring during
physician-advised change or withdrawal of medication require
three months off driving if the previously effective treatment is
reinstated.
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practitioner makes a statement concerning the patient’s condition in
relationship to obtain a driving license: The ultimate/formal authority
to decide whether the person is allowed to drive or not lies with dif-
ferent authorities in the different countries.
The use of EEG data in the evaluations, in addition to consideration
of the duration of the period of freedom from seizures, is not straight-
forward. Discharges of epileptiform activity in the EEG can have dif-
ferent durations and frequencies, and can also have different effects on
cognition and responsiveness. Interpretations of these issues are left
open for the neurologist to decide upon.
This study was performed in order to obtain insights in how fitness-
to-drive evaluations are conducted by epileptologists at tertiary epi-
lepsy centers across Europe, and to learn about how the challenges are
handled in daily practice.
2. Methods
An online survey (suppl. data) was created using the Questback
system (http://www.questback.com), and contact persons in the E-pi-
lepsy and Epi-Care network in epilepsy centers in Europe were sent
invitations by email with a link to the questionnaire. It was assumed
that these contact persons represent the main opinions on these issues
in their country, but the recipients could forward the survey to col-
leagues should they not personally have experience with fitness-to-
drive evaluations. The invitations were first sent in December 2018, and
reminders were sent to non-responders up to four times until February
2019.
If the answer to the first question as to whether the center was in-
volved in fitness-to-drive issues was “No”, the survey was completed. If
the answer was “Yes”, 49 further questions were introduced with the
intention of obtaining information on practices on fitness-to-drive
evaluations regarding Group 1 (ordinary) driving licenses. The ques-
tions were grouped as: (i) general characteristics of the center; (ii)
routines in conducting fitness to drive evaluations; and (iii) opinions on
the need for more regulations, guidelines, or research on these topics.
3. Results
Of the 63 contacts invited to participate in the survey, 35 (56 %)
responded by answering the initial questions in the questionnaire. Of
these, seven (20 %) answered that their centers were not involved in
this issue for PWE; the other 28, representing 26 different epilepsy
centers, answered that their centers were conducting such evaluations
for PWE and answered all 49 subsequent questions in the questionnaire.
Some of the main results from this questionnaire are summarized in
Table 2.
3.1. General characteristics
Among the 28 participants completing the full questionnaire, 16
different European countries were represented from one to five centers,
Table 2
Main questions from survey with results on practices on conducting fitness-to-
drive evaluations are done, n (%).
Have routines been established at your center for estimating the risk of seizures?
Yes 11 (39.3 %)
No 17 (60.7 %)
Which seizure types would be acceptable for FTD in a patient being evaluated at your
center? (MCP)
No seizures at all 17 (60.7 %)
Sleep-related seizures 22 (78.8 %)
Focal seizures without impaired awareness and motor
symptoms
19 (67.9 %)
Seizures starting with an aura evolving to any seizure
type
2 (7.1 %)
Othera 5 (17.9 %)
How much impact does EEG has on your decision about the FTD? (OCP)
None 1 (3.6 %)
Low 10 (35.7 %)
Medium 11 (39.3 %)
High 6 (21.4 %)
Which types of EEG are used? (MCP)
No EEG 1 (3.5 %)
Standard EEG 20 (71.4 %)
Sleep-deprived EEG 10 (35.7 %)
24 h ambulatory EEG 4 (14.3 %)
12–24 h long-term video EEG 16 (57.1 %)
Which other test procedures are used? (MCP)
Hyper-ventilation 24 (85.7 %)
Photic stimulation 23 (82.1 %)
Clinical verbal testing during pathology 16 (57.1 %)
Reaction-time testing (RT) 12 (42.9 %)
Driving simulator 0
Otherb 4 (14.3 %)
No testing during EEG 9 (32.1 %)
Which duration of generalized discharges (GD) in the EEG do you consider to be
compatible with FTD? (OCP)
No GD acceptable 4 (14.3 %)
Shorter than 1 s 2 (7.1 %)
Shorter than 2 s 2 (7.1 %)
Shorter than 3 s 6 (21.4 %)
Any GD without clinical symptoms 4 (14.3 %)
We use RT 4 (14.3 %)
No opinion 0
Otherc 6 (21.4 %)
Which duration of focal discharges (FD) in the EEG do you consider to be compatible
with FTD? (OCP)
No FD acceptable 3 (10.7 %)
Shorter than 1 s 1 (3.6 %)
Shorter than 2 s 1 (3.6 %)
Shorter than 3 s 5 (17.9 %)
Any FD without clinical symptoms 9 (32.1 %)
We use RT 2 (7.1 %)
No opinion 1 (3.6 %)
Otherc 6 (21.4 %)
How great an increase in reaction time due to epileptic discharges would be considered
acceptable for FTD? (OCP)
No increase acceptable 4 (14.3 %)
Maximum 100 ms 3 (10.7 %)
Maximum 300 ms 1 (3.6 %)
Maximum 500 ms 3 (10.7 %)
Maximum 1 s acceptable 2 (7.1 %)
No opinion 11 (39.3 %)
Otherd 4 (14.3 %)
Table 2 (continued)
What is the maximum frequency of GD considered to be compatible with FTD? (OCP)
1 pr minute 1 (3.6 %)
1 pr 15 min 5 (17.9 %)
1 pr hour 0
1 pr 4 h 4 (14.3 %)
1 pr day 0
No GD accepted 4 (14.3 %)
No opinion 14 (50 %)
FTD = fitness to drive, GD = generalized discharges, FD = focal discharges,
RT = reaction time testing, MCP = multiple choice possible, OCP = only one
choice possible.
a “Subtle myoclonias” and “Reflex seizures where stimulus can be avoided”.
b “Cognitive activation like Hanoi Tower”, “Psychological test batteries” and
“Driving test with an expert”.
c “Clinical testing“.
d “We don’t have rules for this” and “RT is compared to individual baseline
testing without EEG discharges”.
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with 22 of the participants based in countries within the EU (Croatia 1,
Czech Republic 1, Finland 1, France 2, Germany 5, Greece 1, Hungary
3, Italy 1, Lithuania 1, Netherlands 1, Romania 2, Spain 1, Sweden 1,
UK 1, and 6 from non-EU countries (Norway 2 and Switzerland 4).
All 28 of these participants reported that epileptologists were in-
volved in conducting the fitness-to- drive evaluations at their centers. In
addition, six (22 %) reported that neuropsychologists were involved in
the evaluations, five (18 %) reported the involvement of clinical neu-
rophysiologists, three (11 %) pediatricians, three (11 %) health per-
sonnel of other specialties, and one participant (4 %) reported that a
general practitioner was involved in the evaluation.
In terms of how many evaluations were conducted, two participants
(7 %) reported their centers conducted 1–10 evaluations annually, nine
(32 %) reported 11–30 per year, three (11 %) reported 31–50 per year,
five (18 %) reported 51–100 per year, and the remaining nine (32 %)
reported that more than 100 such evaluations were conducted annually
at their centers.
3.2. The role of EEG in fitness-to-drive evaluations
Among the 28 participants completing the full questionnaire, 11 (39
%) reported that their national guidelines required EEG in these eva-
luations, and 17 (61 %) reported that EEG results have a medium or
high impact on the outcome of their evaluations.
Use of standard EEG was reported by 20 participants (72 %), and 16
(57 %) used 12−24 h video-EEG long-term monitoring. In addition, 24
(86 %) used photic stimulation and/or hyperventilation, 16 (57 %) used
“clinical verbal testing”, and 12 (42 %) used reaction-time testing. Nine
of the participants (32 %) did not use any kind of behavioral testing
during EEG. None of the participants reported the use of a driving si-
mulator integrated with EEG.
Regarding fitness-to-drive approval and the distribution and dura-
tion of interictal discharges, four (14 %) reported that they would not
approve any PWE for a driving license should generalized discharges be
registered in EEG, 2 (7%) would approve PWE if the generalized dis-
charges were shorter than 1 s, 2 (7%) if shorter than 2 s, 6 (21 %) if
shorter than three seconds and four (14 %) responded that they would
accept longer generalized discharges, provided that there were no
clinical symptoms. 4 (14 %) stated they used reaction time tests to
decide and 6 (21 %) stated they used clinical testing to decide. Focal
discharges were considered more acceptable than generalized dis-
charges. Regarding the frequency of interictal discharges, 14 partici-
pants (50 %) had no opinion concerning generalized discharges, and 16
(57 %) had no opinion concerning focal discharges.
Regarding how large an increase in reaction time due to epileptic
discharges would be considered acceptable, 11 participants (39 %) had
no opinion, and four (14 %) accepted no increase in reaction time. In
contrast, three participants (11 %) would accept increases of 100 mil-
liseconds (ms), one (4%) would accept increases of 300 ms, three (11
%) would accept 500 ms increases, and two (7%) considered 1000 ms
as the maximum acceptable increase in reaction time.
3.3. Opinions on regulations and need of more research
The participants were asked to provide information regarding the
extent to which they agreed with several statements regarding regula-
tions and research on fitness-to-drive evaluations. The responses are
summarized in Table 3.
The statement “Regulations from the authorities are adequate for
evaluating fitness to drive in people with epilepsy” was agreed with by 14
participants (50 %) (Options 4 + 5 in Table 3), whereas 10 participants
(36 %) agreed with the statement “Regulations from the authorities are
sufficiently detailed for conducting a fair and objective evaluation of fitness
to drive in PWE”. This small difference in opinion on fitness-to-drive
evaluations became clearer with the responses to the next question, for
which 13 participants (46 %) agreed that “Regulations from the autho-
rities […] should be more detailed”. In addition, 23 participants (82 %)
agreed that there was a need for more research on how to better
evaluate fitness-to-drive in people with epilepsy, and 25 (89 %) agreed
that regulations on fitness to drive evaluations should be internationally
coordinated. Furthermore, 24 participants (86 %) also agreed that there
was a need for recommendations for PWE who want to use vehicles
with autonomous car technologies.
4. Discussion
The results of this survey indicate differences between European
epilepsy centers regarding fitness-to-drive evaluations of PWE.
Opinions regarding use of EEG examination in these evaluations and
how generalized and focal discharges without clinical symptoms should
be considered for the fitness to drive varied greatly. These differences
indicate a considerable lack of consensus on how fitness to drive eva-
luations should best be conducted, which may reflect the lack of evi-
dence-based guidelines.
Several publications have reported on the effect of epileptiform
discharges on cognition. Browne et al. [9] showed in 1974 that even
during short general discharges of under 1 s, and without observable
seizure symptoms, most patients stopped completely in their con-
tinuous motor-performance task. However, EEG discharges of similar
appearance can be associated with impaired responsiveness in some
patients, but have no discernible impact in others [10]. Despite PWE
responding appropriately during generalized discharges, reaction times
can be considerably delayed [11,12] and could contribute to relevant
and observable lateral drifts of vehicles in real traffic [13]. To the au-
thors’ knowledge, use of the results from these studies in establishing
guidelines on how to use EEG in fitness-to-drive evaluations has not
been attempted.
Although PWE may consider themselves seizure free, these studies
raise the question regarding the extent to which the patients can be
considered genuinely free of seizures, as it is open to debate how long a
cognitive impairment due to epileptiform discharges can last before it
should be defined as a short absence or dyscognitive seizure [14].
It can also be discussed if the frequency of such episodes should be a
Table 3
Responses on opinions on research, guidelines, and regulations regarding fitness-to-drive evaluations, n (%).
1 “Totally
disagree”
2 3 4 5 “Totally agree”
“Regulations from the authorities are adequate for evaluating FTD in PWE.” 3 (10.7 %) 4 (14.3 %) 7 (25.0 %) 12 (42.9 %) 2 (7.1 %)
“Regulations from the authorities are sufficiently detailed for conducting a fair and objective
evaluation of FTD in PWE”
3 (10.7 %) 8 (28.6 %) 7 (25 %) 5 (17.9 %) 5 (17.9 %)
“Regulations from the authorities on how to evaluate FTD in PWE should be more detailed” 4 (14.3 %) 4 (14.3 %) 7 (25 %) 2 (7.1 %) 11 (39.9 %)
“It is easy to evaluate pathological EEG findings in seizure-free patients with regard to FTD.” 4 (14.3 %) 7 (25 %) 6 (21.4 %) 6 (21.4 %) 5 (17.9 %)
“Regulations on evaluation of FTD in PWE should be internationally coordinated “ 1 (3.6 %) 1 (3.6 %) 1 (3.6 %) 6 (21.4 %) 19 (67.9 %)
“There is a need for more research on how to evaluate FTD in PWE” 0 (0%) 3 (10.7 %) 2 (7.1 %) 6 (21.4 %) 17 (60.7 %)
“Recommendations have to be established for epilepsy patients who want to use vehicles with
autonomous car technologies”
0 (0%) 1 (3.6 %) 3 (10.7 %) 6 (21.4 %) 18 (64.3 %)
FTD = fitness to drive. PWE = people with epilepsy.
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separate factor when conducting risk assessments and fitness-to-drive
evaluations.
4.1. Limitations of study
The 28 participants who completed the survey are only a small
fraction of all the epileptologists conducting fitness-to-drive evaluations
in Europe, and this may limit the validity of the survey. However, the
high number of evaluations performed at the centers associated with
the participants in the survey indicates that they have considerable
experience with such evaluations. We therefore assume that the results
can be considered indicative of the major opinions of these issues in
tertiary epilepsy centers in Europe.
5. Conclusion
Our survey showed considerable variations among European epi-
leptologists regarding use of EEG and how findings of EEG pathology
should be assessed in fitness-to-drive evaluations. There is also little
agreement between centers on the significance of prolonged reaction
times during epileptiform discharges and fitness to drive.
Most of the participants who completed the questionnaire agreed
that there was a need for more research and international guidelines on
how to conduct evaluations of fitness to drive in PWE. This widespread
opinion strongly supports the need for further research in this field.
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